Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Lisata Therapeutics Inc (LSTA)

Lisata Therapeutics Inc (LSTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Lisata Therapeutics Inc 110 ALLEN ROAD SECOND FLOOR BASKING RIDGE NJ 07920 USA

www.lisata.com Employees: 26 P: 908-842-0100

Sector:

Medical

Description:

Lisata Therapeutics Inc. is a clinical-stage biopharmaceutical company. It involved in discovery, development and commercialization of therapies for the treatment of advanced solid tumors and other major diseases. The company's principal product candidate includes LSTA1. Lisata Therapeutics Inc., formerly known as Caladrius Biosciences Inc., is based in BASKING RIDGE, N.J.

Key Statistics

Overview:

Market Capitalization, $K 18,171
Enterprise Value, $K 1,961
Shares Outstanding, K 8,821
Annual Sales, $ 1,000 K
Annual Net Income, $ -19,990 K
Last Quarter Sales, $ 70 K
Last Quarter Net Income, $ -4,660 K
EBIT, $ -22,010 K
EBITDA, $ -22,290 K
60-Month Beta 1.09
% of Insider Shareholders 9.60%
% of Institutional Shareholders 8.94%
Float, K 7,974
% Float 90.40%
Short Interest 18
Short Float 0.20%
Short Volume Ratio 0.37

Growth:

1-Year Return -21.77%
3-Year Return -17.60%
5-Year Return -90.96%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 91.49%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.49 on 11/06/25
Next Earnings Date 02/26/26
Earnings Per Share ttm -2.23
EPS Growth vs. Prev Qtr 9.26%
EPS Growth vs. Prev Year 16.95%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-15 on 09/15/22

LSTA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -79.04%
Return-on-Assets % -65.79%
Profit Margin % -1,999.00%
Debt/Equity 0.00
Price/Sales 18.17
Price/Cash Flow N/A
Price/Book 1.05
Book Value/Share 2.41
Interest Coverage -0.72
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar